Edition:
United States

ArQule Inc (ARQL.OQ)

ARQL.OQ on NASDAQ Stock Exchange Global Market

1.51USD
8 Dec 2017
Change (% chg)

$-0.01 (-0.66%)
Prev Close
$1.52
Open
$1.51
Day's High
$1.52
Day's Low
$1.46
Volume
29,006
Avg. Vol
43,877
52-wk High
$1.67
52-wk Low
$0.92

Chart for

About

ArQule, Inc. is a biopharmaceutical company. The Company is engaged in the research and development of therapeutics to treat cancers and rare diseases. These drugs focuses on the biological pathways implicated in a range of cancers and certain non-oncology indications. Its clinical-stage pipeline consists of over four drug... (more)

Overall

Beta: 1.35
Market Cap(Mil.): $131.54
Shares Outstanding(Mil.): 87.11
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 186.11 15.67
EPS (TTM): -- -- --
ROI: -- -11.32 34.62
ROE: -- -35.69 16.00

BRIEF-ArQule Files For Offering Of Up To 17.1 Million Shares

* ARQULE INC FILES FOR OFFERING OF UP TO 17.1 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING Source text for Eikon: (http://bit.ly/2ivqMQn) Further company coverage:

Dec 06 2017

BRIEF-Arqule reports dosing in registrational trial of FGFR inhibitor

* Arqule announces dosing in a registrational trial of fgfr inhibitor, derazantinib, for treatment of intrahepatic cholangiocarcinoma

Nov 21 2017

BRIEF-Arqule reports Q3 loss per share $0.09

* Q3 earnings per share view $-0.11 -- Thomson Reuters I/B/E/S

Nov 09 2017

BRIEF-ArQule announces $9.5 mln private placement of preferred stock

* ArQule announces $9.5 million private placement of preferred stock

Nov 08 2017

BRIEF-Arqule announces $15.7 mln private placement of common stock

* Arqule announces $15.7 million private placement of common stock

Oct 16 2017

BRIEF-Arqule Inc CEO Paolo Pucci​ buys 19,156 shares of co's common stock on Sept 5

* Arqule Inc CEO Paolo Pucci​ reports purchase of 19,156 shares of co's common stock on Sept 5 at average price of $1.14 per share - SEC filing Source text: (http://bit.ly/2j4eXnk) Further company coverage:

Sep 06 2017

BRIEF-Arqule Q2 loss per share $0.10

* Q2 earnings per share view $-0.11 -- Thomson Reuters I/B/E/S

Aug 04 2017

Competitors

Earnings vs. Estimates